medicines


Articles

Leaked: What’s in Obama’s trade deal

1-Jul-2015 Politico A recent draft of the Trans-Pacific Partnership free-trade deal would give US pharmaceutical firms unprecedented protections against competition from cheaper generic drugs, possibly transcending the patent protections in US law.

  • 14-Aug-2014 Canadian Press
    Leaked EU trade pact suggests Canada caved on drug patents

    A leaked copy of the full text of the Canada-EU free trade agreement was posted online late Wednesday and appeared to confirm the fears of the deal’s critics on both sides of the Atlantic.

  • 25-Jul-2014 Macro Business
    AMA warns on risks lurking in TPP trade deal

    The Australian Medical Association (AMA) has urged the Australian government to reject provisions in the Trans Pacific Partnership agreement (TPP) that “could undermine the Pharmaceutical Benefits Scheme and compromise the ability of governments to improve public health”.

  • 2-Jul-2014 Inca Kola News
    The US / Peru Free Trade Agreement and generic medicines

    Peru’s National Association of Pharmaceutical Laboratories (Alafarpe) has filed a petition in the Peruvian courts to stop generic drugs from being sold based on the terms of US-Peru free trade agreement, according to Inca Kola News

  • 30-Jun-2014 El Global
    El sector del genérico pide que el TTIP no armonice aspectos de propiedad intelectual

    El conflicto entre medicamentos innovadores y genéricos se reproduce a costa del Tratado de Libre Comercio entre la Unión Europea y los Estados Unidos (TTIP, por sus siglas en inglés).

  • 26-Jun-2014 Observador Sudamericano de Patentes
    TPP retrasará entrada de 5 mil medicamentos genéricos en México

    Las modificaciones propuestas a la Ley de Propiedad Industrial en el TPP consideran extensiones de patente o la posibilidad de realizar modificaciones a medicamentos que ya perdieron exclusividad.

  • 26-Jun-2014 SBS
    Free trade agreement threatens PBS

    The threat of the Transpacific Partnership Agreement to Australia’s Pharmaceutical Benefits Scheme is so real that Michael Moore, CEO of the Public Health Association of Australia, has said “It will cost Australian lives".

  • 20-May-2014 La República, Perú
    Perú: TPP pone en riesgo el acceso a medicamentos baratos

    Adifan y RedGe demandan que el gobierno negocie dicho acuerdo comercial en beneficio de todos los peruanos. Plantean que no se ceda más allá de lo que se aceptó en el TLC con Estados Unidos.

  • 20-May-2014 No al TTIP
    Análisis de la Federación de Asociaciones para la Defensa de la Sanidad Pública sobre la negociación de la Asociación Transatlántica para el comercio y la inversión (TTIP)

    La experiencia de anteriores acuerdos internacionales de libre comercio señala que favorecen la liberalización del flujo de mercancías, pero no la libre circulación de trabajadores, limitan la capacidad de negociación de los sindicatos, reducen los salarios y elevan la desigualdad social.

  • 8-Apr-2014
    Free trade agreements contain provisions that restrict access to medicines: UNITAID

    UNITAID, a global health initiative has warned against bilateral and regional trade agreements, pushed mostly by Europe and the US, as such agreements go well beyond traditional trade concerns and include provisions that force extensive obligations related to intellectual property and investor protection which would restrict access to medicines.

  • 7-Apr-2014 Focus
    Free trade agreements threaten access to medicine by the poor in Philippines

    Ambitious free trade agreements in the Philippines would pose serious threats to access to medicines for the poor by providing greater patent rights to pharmaceutical companies, the EU-ASEAN Campaign Network said Tuesday ahead of an international meeting of pharmaceutical companies in Manila.

  • 24-Mar-2014 Commons Network
    TTIP and the big pharma wish-list

    A report by the Commons Network and civil society partners shows that the pharmaceutical industry’s wish list for the TTIP is detrimental for public health, will increase the cost of medicines and undermines democratic processes

  • 27-Jan-2014 RTS
    Possible retard de l’accord de libre-échange entre la Suisse et l’Inde

    Le conseiller fédéral suisse Johann Schneider-Ammann a laissé entendre samedi dans la presse alémanique que la question de la protection des brevets pourrait retarder l’accord de libre-échange avec l’Inde.

  • 16-Dec-2013 CMAJ
    Canadians balk at longer brand-name drug patents

    Nearly two-thirds of Canadians oppose longer patents for brand-name drugs under a proposed trade deal with the European Union, according to a poll commissioned by the Council of Canadians.

  • 12-Dec-2013 IP Watch
    The EU-Thailand FTA: What fate for access to medicines?

    Following the public outcry over the EU’s demands for stringent intellectual property rules that would dramatically raise medicines prices in India, you would expect the EU to think twice about making similar demands in future trade agreements. Yet, this is precisely what is going on now in the negotiations for a free trade agreement between the EU and Thailand.

  • 11-Dec-2013 Tribune de Genève
    L’accord de libre-échange avec l’Inde inquiète les pharmas

    Bruxelles n’a pas accepté la politique de licence que défend New Delhi, principalement dans la pharma. C’est précisément ce point —la protection de la propriété intellectuelle— qui inquiète la branche en Suisse.

  • 11-Dec-2013 Financial Chronicle
    EU-US free trade pact cause of concern for Indian pharma firms

    There are apprehensions that TTIP would prevent Indian pharma companies to come to market with the same products - they would need to pass through several rounds of additional tests. As a result, prices will move up significantly.

  • 13-Nov-2013
    Roadblocks revealed in TPP talks

    Leaked details of free trade negotiations between New Zealand and the United States show the two countries are in stark opposition on a number of key areas.

  • 9-Nov-2013
    CETA is more about corporate rights than free trade

    Since announcing the Comprehensive Economic and Trade Agreement (CETA) two weeks ago Harper’s Conservatives have repeatedly labelled those questioning the deal as “anti-trade”. But this Canada-European Union accord is one part trade and four parts ‘corporate bill of rights’.

  • 8-Nov-2013
    Ottawa challenged to release internal estimates of Europe free-trade drug costs

    The federal government won’t release internal documents that may predict potential higher drug costs for Canadians under new patent rules agreed to in the free-trade deal with Europe, Trade Minister Ed Fast says.

  • 3-Nov-2013
    Canada-EU trade agreement presages IP reform

    The far reaching provisions of the Comprehensive Economic and Trade Agreement between Canada and the European Union will have considerable impact on Canada’s IP regime.

  • 0 | 20 | 40 | 60 | 80 | 100 | 120 | 140 | 160 | ... | 480